Artwork

Treść dostarczona przez LearnSkin: Integrative Dermatology and Education. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez LearnSkin: Integrative Dermatology and Education lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Player FM - aplikacja do podcastów
Przejdź do trybu offline z Player FM !

Episode 131: JAK Updates for Psoriasis

33:40
 
Udostępnij
 

Manage episode 338237775 series 2986265
Treść dostarczona przez LearnSkin: Integrative Dermatology and Education. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez LearnSkin: Integrative Dermatology and Education lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Do you know JAK? If not, then you're about to. This week, we're joined by Dr. Jason Hawkes as he breaks down the specifics of JAK inhibitors, their safety profiles, the JAK-STAT pathway, and more. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Jason Hawkes, MD MS is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program’s 2+2 dermatology research track. In addition to being a board-certified dermatologist, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master’s degree in Clinical Investigation from Rockefeller University in NYC. Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation (NPF) and as a Councilor of the International Psoriasis Council (IPC). He is the recipient of multiple teaching awards and research grants and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 50 peer-reviewed publications and 8 book chapters. Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel, targeted systemic or biologic therapies. To learn more about JAK inhibitors and psoriasis, attend Dr. Hawkes' lecture at the 2022 Integrative Dermatology Symposium.
  continue reading

100 odcinków

Artwork
iconUdostępnij
 
Manage episode 338237775 series 2986265
Treść dostarczona przez LearnSkin: Integrative Dermatology and Education. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez LearnSkin: Integrative Dermatology and Education lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Do you know JAK? If not, then you're about to. This week, we're joined by Dr. Jason Hawkes as he breaks down the specifics of JAK inhibitors, their safety profiles, the JAK-STAT pathway, and more. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Jason Hawkes, MD MS is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program’s 2+2 dermatology research track. In addition to being a board-certified dermatologist, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master’s degree in Clinical Investigation from Rockefeller University in NYC. Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation (NPF) and as a Councilor of the International Psoriasis Council (IPC). He is the recipient of multiple teaching awards and research grants and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 50 peer-reviewed publications and 8 book chapters. Dr. Hawkes’ principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel, targeted systemic or biologic therapies. To learn more about JAK inhibitors and psoriasis, attend Dr. Hawkes' lecture at the 2022 Integrative Dermatology Symposium.
  continue reading

100 odcinków

Wszystkie odcinki

×
 
Loading …

Zapraszamy w Player FM

Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.

 

Skrócona instrukcja obsługi